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Objective: To establish the performance of a location-speciﬁc computer-assisted quantitative measure of
hip joint space width (JSW), by measuring responsiveness in those with hip osteoarthritis (OA) and pain
and those without. Secondary purposes included investigating the most responsive location and com-
parison to minimum joint space width (mJSW).
Methods: Design: nested caseecontrol.
Data: from the Osteoarthritis Initiative (OAI), a longitudinal cohort study of knee OA. All participants had
standardized standing anterior-posterior (AP) pelvis radiographs at baseline and 48 months.
Case deﬁnition (1): subjects with a total hip replacement (THR) after the 48 month visit (n ¼ 27) were
selected and matched (1:1) on sex and age to subjects without a THR.
Case deﬁnition (2): subjects with a THR at any point after baseline (n ¼ 79) were selected and the
contralateral (CL) hip was designated the case hip, and subjects were matched (1:1) as above.
Pain: the CL hip group were examined for the presence/absence of pain.
Measurements of superior hip JSW were made at three ﬁxed locations relative to a landmark-based line,
facilitated by software.
The standardized response mean (SRM) was used to examine sensitivity to change from baseline to 48
months. Paired t-tests were used to compare cases and controls.
Results: Signiﬁcant differences were observed between cases and controls and those with and without
pain. The location-speciﬁc measure outperformed mJSW in all analyses, with SRM ranging from 0.53
(contralateral hip) to 1.06 (THR hip). The superior-medial location was most responsive.
Conclusion: A new computer-assisted location-speciﬁc measure of hip JSW may provide a superior
method to mJSW for radiographic OA progression. The superior-medial locationwas the most responsive.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Expert consensus groups1,2 and the United States Food and Drug
Administration (FDA)3 have stated that radiographic joint space
width (JSW) in hip osteoarthritis (OA) is adequate (and the only
FDA-recommended) method for evaluation of structural change in
hip OA intervention trials. Hip JSW has received limited research
attention in comparison with the knee, even though it is likely a
more direct measure of cartilage thickness. At the knee a sub-
stantial proportion of radiographic JSW loss is due to factors other. Ratzlaff, Radiology, Brigham
ancis Street, Thorne Building,
A.
zlaff).
ternational. Published by Elsevier Lthan cartilage thickness, including meniscal damage, meniscal
extrusion and variability in patient positioning2,4,5. By contrast, the
hip does not have menisci and patient positioning in standardized
anteroposterior pelvic radiography is less problematic.
Despite its importance in drug and therapy development, the
relevance of JSW as an outcome remains somewhat doubtful6.
Responsiveness is a key issue since progression of disease is
frequently slow and variable. The best and most commonly metric
is minimum joint space width (mJSW), measured manually or with
computer assistance. The most responsive and suitable mJSW is
with a computer-assisted method6,7. Either way the location of
mJSW is subjectively selected, can be time-consuming, susceptible
to structural damage that can confound joint margin detection or
cause inconsistencies including measurement at different locations
(within and between subjects) on serial radiographs, leading totd. All rights reserved.
Fig. 1. Example of location-speciﬁc hip JSW measurement.
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responsive and efﬁcient computer-assisted measure of hip JSW
could be a signiﬁcant advance for large cohort studies and trials.
To address these issues at the knee, we previously developed
and validated a semi-automated software measure of location-
speciﬁc JSW relative to a coordinate system, which was found to
be more responsive and robust than mJSW and has been used in
numerous studies9. We now extend a similar computer-assisted
method of ﬁxed location measurement of JSW to the hip.
The primary purpose of this study was to establish the perfor-
mance of a novel location-speciﬁc computer-assisted quantitative
software measure of hip JSW, by measuring responsiveness at ﬁxed
locations in those with hip OA and pain and those without. Sec-
ondary purposes included investigating the most disease-
responsive location, comparing the location-speciﬁc measure-
ment to mJSW and evaluating the reading time required.
Methods
Subjects
Data used in the preparation of this article were obtained from
the Osteoarthritis Initiative (OAI) database, which is available for
public access at http://www.oai.ucsf.edu/. The OAI is a multi-center
longitudinal cohort study of biomarkers and risk factors for the
development and progression of knee OA in 4,796 subjects. General
exclusion criteria (for all OAI participants) included rheumatoid or
inﬂammatory arthritis, bilateral end-stage knee OA and MRI con-
traindications. A full description of study protocol, design, data
overview and the datasets are available for public access at http://
www.oai.ucsf.edu/. The study was HIPAA compliant and all subjects
provided informed consent. The study protocol, amendments and
informed consent documentation were reviewed and approved by
the local institutional review boards.
Image acquisition
All OAI participants had standing anterior-posterior (AP) ra-
diographs at baseline and 48 month visits using a standardized
protocol. Radiographs were performed in the weight-bearing po-
sition using a positioning frame (“SynaFlexor”, TM)with the subject
facing the X-ray tube, the feet internally rotated 5 with assistance
of a v-shaped foot angulation support and the body weight
distributed equally between the two legs. The X-ray beam was
horizontal, perpendicular to the ﬁlm and centered two inches
above the pubic symphysis at the level of the greater trochanter,
collimated to the size of the ﬁlm with the iliac bones included
entirely. The radiography protocol called for an extremity detail
ﬁlm cassette (Agfa Ortho Fine), with a 40 inch ﬁlm to focus distance.
The radiography technique called for a 70e80 kVp range with a
variable mAs.
Study sample and design
For the current study we used a nested caseecontrol design. We
used two case deﬁnitions.
Total hip replacement (THR)
Subjects who had a THR sometime after the 48 month visit (at 60
and 72 months) and therefore had AP pelvic ﬁlms at 0 and 48
months, were selected. After eliminating those with unavailable or
poor quality ﬁlms, 27 cases were included andmatched (1:1) on sex
and age (2 years) to subjects without a THR and no hip pain during
the study period.Contralateral hip of a THR
Since there is evidence that JSW narrowing occurs in the
contralateral hip after THR10 and since hip OA severe enough to
require THR likely alters the biomechanics of contralateral joint
loading, we also deﬁned a second larger set of cases. This included
all subjects who had a THR at any point after baseline and had good
quality AP pelvis ﬁlms at 0 and 48 months (n ¼ 79) for the
contralateral hip. Subjects were matched (1:1) as above.
Pain
The primary pain deﬁnition was pain in the groin and/or the
front of the leg near the hip. Since lateral pain can sometimes be
from articular hip pain but is frequently the result of non-hip joint
sources such as the low back and local soft tissue11,12, we also
collected data on lateral hip pain to use as part of the pain deﬁnition
in a sensitivity analysis of the pain outcome.
To collect data on pain, subjects were asked at each OAI visit the
following two-stage question regarding hip pain:
1. “During the past 12 months, have you had any pain, aching, or
stiffness in or around your right hip? This includes pain in the
groin and in the front and sides of the upper thigh.”
If the reply was yes, they were asked a follow-up location that
included the following as multiple-choice answers:
2. “Where is this pain, aching, or stiffness located? Please look at
this drawing and point to all the places you have hip pain.”
(Subjects were shown a diagram by the examiner with the areas
of the hip indicated to guide selection).
1) Groin/Inside leg near hip
2) Outside of leg near hip
3) Front of leg near hip
Measurement of JSW at ﬁxed locations. The procedure was modeled
after a previously developed and validated method at the knee
which was found to be more responsive and robust than mJSW and
had good reliability9. At the hip, an analogous methodology was
employed. Measurements of superior hip JSW were made at three
ﬁxed locations relative to a line extending from the femoral head
center to the outer edge of the acetabular roof (Fig. 1, red line).
While a Cartesian coordinate systemwas used to establish locations
in the knee joint, polar coordinates were used for the hip.
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radiograph at the lateral edge of the acetabular roof, and the
computer delineated the femoral head and found its center. A line
was then placed by the computer between these two points, as well
as at 10, 30 and 50 medial to the reference line.
Position 1 (Fig. 1) was in the supero-lateral hip and was 10 to
the right of the line (both left and right hips were oriented the same
way to facilitate software operation). Position 2 was supero-central
and was 30 from the line. Position 3 was supero-medial and was
50 from the line. The process was semi-automated, facilitated by
software that delineated the femoral head and found the acetabular
margin along each of the lines. When required, a reader used a
graphical user interface software tool to correct margins.
Measurement of mJSW. mJSW was measured as the minimum dis-
tance between the delineated femoral and acetabular margins in
the superior compartment. The software delineated the femoral
head and reader judgment was employed to select the point on
acetabulum which represented mJSW.
For all JSW measures (location-speciﬁc and mJSW), image ﬁles
were prepared by a different researcher than the reader and
randomly assigned ﬁlenames ensured that the reader had no
knowledge of the correct time sequence. Baseline and follow-up
images were displayed separately such that the reader was blind
to chronological sequence.
Reliability
Reliability was assessed on a random sample of 20 subjects. For
intra-rater reliability, readings were separated in time by 8 weeks
to avoid recall bias. Inter-reader reliability was assessed on the
same 20 cases by an experienced radiologist (CV).
Statistical analysis
Hip JSW (mm) was calculated by the computer for each hip at
baseline and 48 month follow-up and the 48 month mean changeTable I
Subject characteristics
Characteristics Hips that received THR
after 48 months OAI
visit (n ¼ 27 hips)
Controls (n ¼ 27 hips) P-va
Agex, yr 62.9 (8.7) 63.0 (8.9) e
Sexx
Male 12 12 e
Female 15 15
BMI baseline 27.4 26.9 0.61
Ethnicity
Caucasian 26 24 0.63
Other 1 3
*Baseline mJSW 2.89 (1.12) 3.48 (0.59) 0.02
Baseline JSW 1 5.05 (1.53) 5.23 (1.01) 0.63
Baseline JSW 2 4.85 (1.28) 5.24 (1.17) 0.26
Baseline JSW 3 4.80 (0.98) 4.66 (0.86) 0.59
4-year mJSW 1.89 (1.01) 3.52 (0.85) 0.00
4-year JSW 1 3.54 (1.77) 5.20 (1.01) 0.00
4-year JSW 2 3.59 (1.60) 5.16 (1.06) 0.00
4-year JSW 3 3.51 (1.26) 4.67 (0.86) 0.00
4-year D in mJSW 1.18 (1.18) 0.06 (0.71) 0.00
4-year D in JSW 1 1.51 (1.43) 0.03 (0.53) 0.00
4-year D in JSW 2 1.25 (1.60) 0.08 (0.54) 0.00
4-year D in JSW 3 1.29 (1.24) 0.01 (0.50) 0.00
Bold indicates statistically signiﬁcant difference.
* All JSW measures in mm.
y From paired t-tests.
z McNemar's test.
x Matched cases and controls.(and standard deviation) for all three locations and mJSW were
calculated. As a metric to quantify performance we used the stan-
dardized response mean (SRM), or the ratio of the mean loss to the
standard deviation of the loss.We report the SRM values alongwith
themeans (SD) at baseline and 48months, themean (SD) 48month
change for each case and control group, and for those with and
without hip pain in the contralateral hip group. We also compared
the location-speciﬁc to mJSW for both case groups. Paired t-tests
were used to test statistical signiﬁcance between cases and controls.
Since it is often not clear whether lateral hip pain is of hip-
articular origin or from outside the hip joint11,12 particularly in
early to moderate disease, we conducted a sensitivity analysis
where lateral hip pain was included in the deﬁnition. We hypoth-
esized (based on lateral hip pain often being of low back or local
soft tissue origins), that it would substantially increase the number
of contralateral hips with hip pain and attenuate the relationship
between pain and change in JSW.
For both intra-reader and inter-reader reliability, the Shroute-
Fleiss intra-class correlation coefﬁcients (ICC) were calculated as
measures of agreement.
Results
The overall samplewas 42%male, 88% Caucasian had amean age
of 64.2 and BMI of 27.9.
Baseline JSW for cases and controls were similar and were not
signiﬁcantly different, with the exception of mJSW for THR cases
(cases 2.89 mm, controle 3.48mm p¼ 0.02) (Table I). At the 4-year
follow-up, signiﬁcant differences were observed between cases and
controls in both groups for mJSW and location-speciﬁc JSW
(Tables I and II; Fig. 2). For the THR group, the mean loss in JSW at
superior-lateral position (1) was 1.51 mm, while at the superior-
medial position (3) it was 1.29 mm. The SRM for location 1 and 3
was 1.06 and 1.04 respectively. For the contralateral hip group,
location 3 was the most responsive with a 4-year change
of 0.40 mm and SRM of 0.53. In both groups controls showed
little change in JSW over 4 years.luey C/L hips (of those with THR
any OAI visit) (n ¼ 79 hips)
Controls (n ¼ 79 hips) P-valuey
63.2 (8.6) 63.2 (8.7) e
32 32 e
47 47
28.8 27.6 0.08
z 69 72 0.63
10 7
3.35 (0.82) 3.48 (0.79) 0.36
5.11 (1.00) 5.36 (1.02) 0.15
5.20 (0.88) 5.21 (1.28) 0.96
4.98 (0.88) 4.90 (1.11) 0.56
3.12 (0.92) 3.46 (0.85) 0.01
4.88 (1.08) 5.33 (1.03) 0.01
4.97 (1.04) 5.18 (1.07) 0.21
4.58 (1.03) 4.77 (1.08) 0.26
0.29 (0.81) 0.01 (0.59) 0.01
0.23 (0.68) 0.03 (0.46) 0.02
0.24 (0.63) 0.03 (0.81) 0.10
0.40 (0.75) 0.13 (0.60) 0.01
Table II
4-year change (baseline to 48 month) in hip JSW in THR hips (and controls) and in contralateral hips of those receiving THR (and controls)
Group 1 (THR) Mean (sd)
DmJSW (mm)
Mean (sd) DJSW 1
(sup-lat) (mm)
Mean (sd) DJSW 2
(superior) (mm)
Mean (sd) DJSW 3
(sup-med) (mm)
SRM mJSW SRM location 1
(sup-lat)
SRM location
2 (superior)
SRM location
3 (sup-med)
THR Cases (n ¼ 27) 1.18 (1.18) 1.51 (1.42) 1.25 (1.60) 1.29 (1.24) 1.00 1.06 0.78 1.04
Controls (n ¼ 27) 0.06 (0.71) 0.03 (0.53) 0.08 (0.54) 0.01 (0.50) 0.08 0.06 0.15 0.02
P-value* 0.000 0.000 0.001 0.000
Group 2 (Contralateral to THR)
Cases (n ¼ 79) 0.29 (0.81) 0.23 (0.68) 0.24 (0.63) 0.40 (0.75) 0.36 0.34 0.37 0.53
Controls (n ¼ 79) 0.02 (0.59) 0.03 (0.46) 0.03 (0.81) 0.13 (0.60) 0.03 0.07 0.04 0.21
P-value* 0.01 0.03 0.07 0.01
Bold indicates statistically signiﬁcant difference.
* From paired t-tests.
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change and SRM were greatest for the superior-medial location (3)
(48 month change 0.90 mm, SRM 0.74). L0.54 in those without
pain (48 month change 0.26 mm).
In all analyses, location 3 (superior-medial hip) outperformed
mJSW as measured by both raw JSW change and SRM.
In the sensitivity analysis of the 79 contralateral hips where the
pain deﬁnition included lateral hip pain we found that 48% (37 of
79) of contralateral hip subjects had lateral hip pain, and that of
these, 29% (23 of 79) had only lateral hip pain. This compares with
22% (17 of 79) that had only groin and/or anterior hip pain. Using
the alternative pain deﬁnition there were no signiﬁcant differences
between painful hips and non-painful hips in either mJSW or
location-speciﬁc JSW, or in the SRMs. In the THR group, 23 of 27
subjects (85%) had lateral hip pain as part of the presentation.
The ICC's for intra-reader reliability were 0.85, 0.80 and 0.88 for
location 1 (sup-lat), 2 (sup-central) and 3 (sup-med), respectively.
For inter-rater reliability, the ICC's were 0.88, 0.93 and 0.84.Discussion
Similar to ﬁndings at the knee9, location-speciﬁc computer
measures of hip JSW are feasible and provide a superior method to
mJSW for radiographic OA progression. Evidence from this study
suggests that the superior-medial hip may be the best location for
measuring longitudinal JSW change in the hip joint, outperforming
mJSW for responsiveness in all analyses. The superior-lateral
location in the most diseased hips performed similarly to the
superior-medial location.
While selecting and measuring the location of perceived mJSW
on each radiographwould intuitively yield the biggest serial change
in JSW, the better location-speciﬁc result may overcome difﬁculties
associated with serial measurement of a degenerating joint. The
enhanced responsiveness may be explained by the need to have
unambiguous joint margins present on the radiographic image to
facilitate consistent delineation of the joint space9. Second the useFig. 2. SRMs in THR hips (and controls) and in contralateral hips of those receiving
THR (and controls).of landmark-based consistent locations that cover the joint space
systematically may be less susceptible to structural damage that
can confound joint margin detection or cause inconsistencies from
baseline to follow-up. Third, once disease becomesmore severe and
approaches bone on bone status e often evident at the medial and
lateral joint margins e the amount of further narrowing is limited,
whereas JSN can be better observed at locations away from the
bone on bone region.
The location-speciﬁc method clearly distinguished 4-year
change in JSW between controls and THR cases. It also distin-
guished 4-year changes between controls and the contralateral
hips of a THR hip. As expected the change was smaller than in the
THR group, but remained signiﬁcant. There was no appreciable
decline in the JSW of controls, consistent with other studies13,14 .
Amongst the contralateral hips the method also detected sig-
niﬁcant differences between those with and without hip (anterior
hip or groin) pain, both at the superior-lateral (1) and superior-
medial (3) locations. At the superior-medial joint the difference
was stronger and more clearly clinically meaningful (mean change
0.90 mm, SRM 0.74).
The method was also reliable and efﬁcient, requiring an average
of 1 min per hip reading time. Other studies have not reported on
the time required to measure hip JSW. A rapid method has the
potential to more cost-effectively study large cohorts (e.g., 1000 s)
in a shorter period.
The superior-medial hip joint space (3) was highly responsive in
both case groups, as well as in those reporting hip pain over the 4
years. The supero-lateral joint space (1) was highly responsive in
the THR group as well (SRM 1.06 vs 1.04). This difference in the
most involved case group (those going onto THR) may reﬂect a
more advanced (i.e., progression) state of disease, though are
sample size was not large. Location 2 (superior-middle) was the
least responsive in all analyses and was only statistically signiﬁcant
in the THR group.
To our knowledge, no other studies have measured location-
speciﬁc change in hip JSW using a robust coordinate system.
However, several studies have reported on JSW from locations
within the superior hip joint space. Lequesne et al. reported on JSW
in 223 healthy subjects. Several other groups report measuring hip
JSW at multiple locations at the hip, although none did so in
reference to an anatomical landmarks and analyzed each location
separately. Measuring the hip JSW at the same ﬁxed location on
baseline and follow-up scans may improve consistency in longi-
tudinal studies, and by selecting the most responsive location,
decrease power and sample size required to observe clinically
meaningful change. The locations of our measurement may vary
across individuals but remain consistent for a given hip.
Other studies have reported variation in mean annual progres-
sion from 0.01 mm to 0.37 mm15e19 in studies of between 1 and 3
years. In comparison, our total mean change in JSW over was
1.51 mm for THR cases at 4 years, at the superior-lateral location for
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annual change may in part be explained by the endpoint of THR, a
more severe from of disease though several other studies have used
a similar endpoint. In the contralateral hips of those with THR, 4-
year change was 0.10 mm/year, similar to the ﬁndings of Goker
et al.10, who measured JSW change in the contralateral after a THR,
to Chevalier et al.15 who measured the contralateral hip of symp-
tomatic OA hip patients (ACR criteria plus KL 2e3) and to other
studies measuring JSW change in established OA hips (i.e., not
contralateral).
The SRM is a better measure for comparing responsiveness be-
tween methods and provides information about the importance of
an identiﬁed difference when using different types of instruments
with different scoring and ranges of variation (i.e., howwell one can
distinguish the “signal” from the “noise”). In general an SRM >0.80
is considered a large effect size20, and the sample size required for a
study drops by a factor of 4 for each doubling of the SRM. The SRM
for THR cases in this study at the superior location was 1.06. Other
studies have reported SRMs ranging from 0.37 to 1.16 over follow-
up periods of 1e8 years15e19,21e24. In a recent systematic review by
Chu et al.6 on the responsiveness of radiographic quantitative
measurement in hip OA in high quality studies, responsiveness was
found to bemoderate (SRM 0.66; 95% conﬁdential interval (95% CI):
0.41, 0.91), though was better in studies that used computer-
assisted vs manual measurement of JSW.
Manual measures have been used traditionally but there is ev-
idence that computer-assisted measures may have better sensi-
tivity. In a 2001 study Conrozier et al.7 investigated several
radiographic measures for hip OA progression and found that
minimum inter-bone distance was the most responsive measure,
and that computer-assisted measure was more responsive than
using a manual eye-piece (SRM: 0.85 vs 0.79). Our computer-
assisted method of location-speciﬁc JSW performed better than
both these ﬁndings, however direct comparison to other studies is
difﬁcult since factors such as the disease status and length of
follow-up time affect the responsiveness.
Our deﬁnition of hip pain deserves comment. Lateral hip pain
was excluded from the primary deﬁnition, based on evidence and
our clinical experience that, especially earlier in disease, it is often
not of articular hip origins. In the sensitivity analysis it was noted
that inclusion of the lateral hip pain changed the result for both
mJSW and location-speciﬁc JSW, supporting the evidence that
lateral hip pain, especially earlier in disease, may not be articular
origin. Of note, in the THR group ewhere the superior-lateral joint
space was as responsive as the superior medial, the vast majority of
cases had lateral hip pain (23 of 27, or 85%) as part of the presenta-
tion, while in the contralateral group 23 of 79 (29%) had only lateral
hip pain and37of 79 (47%)had lateral hippain in addition togroinor
anterior pain. Itmaybe that in some types ofmore severehipdisease
the lateral hip joint becomes increasingly more narrowed and the
hip joint contributes more consistently to lateral hip pain.
A strength of the location-speciﬁc method was that we did not
have to delineate the acetabular margin and the method did notTable III
Baseline to 48 month change in JSW and SRM in contralateral hips of those receiving TH
Anterior hip or
groin pain
Baseline
mJSW
Baseline
JSW 1
Baseline
JSW 2
Baseline
JSW 3
Mean
48 m (sd)
DmJSW
Pain at 1 or more
follow-ups (n ¼ 17)
3.22 (0.93) 5.06 (1.29) 5.29 (1.26) 5.18 (1.05) 0.40 (0.6
No hip pain 0e48
months (n ¼ 62)
3.48 (0.77) 5.12 (0.92) 5.17 (0.75) 4.93 (0.83) 0.31 (0.7
P-value* 0.25 0.82 0.63 0.31 0.67
Bold indicates statistically signiﬁcant difference.
* From t-tests.require selection of the location of the minimum inter-bone dis-
tance e a problemwith mJSWmeasures. Conrozier et al.16 reported
on a novel measure of computer measurement of hipmJSW, ﬁnding
it provided good sensitivity to change, but that it was necessary for
the observer to intervene frequently to select the region of mJSW
and adjust detection of the bone edge. In the current study, we have
overcome problems with selection of mJSW region by selecting
speciﬁc ﬁxed locations. This also overcomes the problem of where
to mark the minimum when there is no local minimum. Another
advantage to location-speciﬁc measures coupled with a computer-
assisted method may be an improvement in reproducibility. It has
been observed by Vignon et al.8 and others that with repeated
measures it is common to have discrepancy in the range of 0.2 mm
(or greater), greater than the average annual JSW loss in hip OA.
Vignon postulated that the primary reason for this is that the
location of JSW measurement were not at identical locations on
repeated measures, i.e., the point of minimum JSW is deﬁned
differently on serial radiograph8. Another strength was the efﬁ-
ciency (<1 min/hip). The method used an automated computer
detection algorithm to demarcate the femoral head and it worked
well. While there was a need for periodic reader intervention to
modify computer selections, it was most often on the acetabular
side and corrections were rapid, since only three spots along the
acetabular margin were required, with the computer usually
locating them accurately. The method is ﬂexible and JSW at loca-
tions other that 10, 30, and, 50 could easily by made.
A signiﬁcant limitation of the study was the relatively small
sample size of the THR group (27 cases, 27 controls), and further
studies in larger cohorts should be undertaken. We also limited
measurement to the superior hip joint space, potentially missing
important changes in the inferior space. However, the superior
space is the most widely used clinically and in the research setting,
and is thought to be the more responsive. Thirdly, the three
measured locations are in relation to a reference line that is located
in part by the computer (center of femoral head) and observer
(lateral margin of acetabular roof) e which could vary on serial
markings. However, we found that these landmarks were highly
reproducible on serial radiographs of the same hip. Lastly, while we
matched cases to controls on age and gender, residual confounding
may persist, particularly if cases had more advanced disease at
baseline than controls. This was the case for the mJSW between
cases and controls for the THR group (Table I). However there were
no signiﬁcant differences for the contralateral hip group, nor for
any of the baseline location-speciﬁc JSW measures in either case-
econtrol group, (there were also no baseline difference between
the pain and no pain group, Table III). Of note, the primary purpose
of the study was to establish the responsiveness of the novel
measure of hip JSW in those with hip OA and pain and those
without and not to predict outcome based on baseline JSW or to
compare groups using a measure of association (e.g., OR). In that
case, the selection of controls could have lead to misclassiﬁcation
(non-differential or differential) and biased a measure of associa-
tion (such as an OR).R (n ¼ 79), by location, by pain status
Mean
48 m (sd)
DJSW 1
Mean
48 m (sd)
DJSW 2
Mean
48 m (sd)
DJSW 3
SRM
mJSW
SRM 1 SRM 2 SRM 3
3) 0.58 (1.06) 0.32 (1.06) 0.90 (1.23) 0.63 0.55 0.30 0.74
5) 0.14 (0.59) 0.21 (0.46) 0.26 (0.49) 0.42 0.24 0.46 0.54
0.02 0.55 0.00
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A new computer-assisted location-speciﬁc method of hip JSW is
feasible and may provide a superior method to mJSW for radio-
graphic OA progression. Evidence from this study suggests that the
superior-medial hip may be the best location for measuring lon-
gitudinal JSW change in the hip joint, outperforming mJSW for
responsiveness in all analyses. The superior-lateral location in the
most diseased hips performed similarly to the superior-medial
location.
It is also rapid, taking approximately 1 min per hip. Location-
speciﬁc measures of JSW are an efﬁcient and possibly improved
method to assess progression of hip OA.
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